Last reviewed · How we verify

NCT01945554: InfStu

The Value of Short-term Pain Relief for the Prediction of Long-term Outcome After Cervical or Lumbar Nerve Root Infiltration

Completed NA Last updated 23 January 2018
What this trial tests

NA trial testing Cervical nerve root infiltration in Cervical Disc Herniation in 250 participants. Completed in 1 March 2017.

Timeline
1 July 2013
Primary endpoint
1 March 2017
1 March 2017

Quick facts

Lead sponsorHolger Joswig
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment250
Start date1 July 2013
Primary completion1 March 2017
Estimated completion1 March 2017
Sites3 locations across Switzerland

Drugs / interventions tested

Conditions studied

Sponsor

Holger Joswig — full company profile →

Who can join

Adults 18 to 70, any sex, with Cervical Disc Herniation or Lumbar Disc Herniation. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

The purpose if this study is to assess the response to nerve root infiltration therapy in patients with cervical or lumbar disc herniations.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cervical Disc Herniation

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01945554.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing